These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 887731)

  • 1. [Xenon 133 muscle clearance in peripheral arterial disorders].
    Kirsch G; Höwner B
    Radiobiol Radiother (Berl); 1977; 18(2):215-24. PubMed ID: 887731
    [No Abstract]   [Full Text] [Related]  

  • 2. 133Xe muscle clearance: a screening test for arterial occlusive disease.
    Pozderac RV; Miller TA; Lindenauer SM
    Radiology; 1975 Dec; 117(3 Pt 1):633-5. PubMed ID: 1188111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [133 Xenon clearance in peripheral vascular diseases].
    Gyurkó G; Lengyel L; Kovács L
    Acta Chir Acad Sci Hung; 1976; 17(3):203-8. PubMed ID: 798456
    [No Abstract]   [Full Text] [Related]  

  • 4. The blood flow in the muscles of upper and lower extremities in patients with a chronic occlusive arterial disease, measured by the xenon-133 clearance technique.
    Derezić D; Ivancević D; Custović F
    Acta Med Iugosl; 1980 Nov; 34(4):279-87. PubMed ID: 7468305
    [No Abstract]   [Full Text] [Related]  

  • 5. Xenon-133 clearance studies during walking; effect on muscle and skin blood flow; routine application with comment on branch thrombosis below the knee.
    Larsen OA
    Scand J Clin Lab Invest Suppl; 1973; 128():89-92. PubMed ID: 4587558
    [No Abstract]   [Full Text] [Related]  

  • 6. [Arterial investigation by Xenon 133 (author's transl)].
    Enjalbert A
    Acta Chir Belg; 1977 Jan; 76(1):55-9. PubMed ID: 848234
    [No Abstract]   [Full Text] [Related]  

  • 7. [Method of local clearance of 133Xe in evaluation of the tissue blood flow in patients with thromboobliterative diseases of the arteries of the lower extremities (literature review)].
    Muradov NF; Samarskaia EV
    Sov Med; 1981; (9):76-9. PubMed ID: 7031910
    [No Abstract]   [Full Text] [Related]  

  • 8. Considerations on occlusive diseases of the leg arteries and determination of muscle blood flow by Xe-133 clearance method.
    Hirai M; Shionoya S
    J Cardiovasc Surg (Torino); 1975; 16(1):35-42. PubMed ID: 1126984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of blood flow in peripheral muscles using Xe133.
    Hinsenkamp M; d'Hollander A; Coussaert E; Rasquin C; Schoutens A
    Angiology; 1980 Jan; 31(1):58-65. PubMed ID: 7369540
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quantitative evaluation of muscle blood flow by the clearance of locally injected 133Xe].
    Frolov VK; Koptev IV; Koshkin VM; Poraĭ-Koshits AK
    Med Radiol (Mosk); 1980 Jul; 25(7):59-65. PubMed ID: 7401960
    [No Abstract]   [Full Text] [Related]  

  • 11. [Muscular clearance of xenon (Xe-133) as a measure of the effectiveness of Provasan and Bametan for the correction of blood flow in the lower limbs].
    Jonderko G; Szramek-Urbaniak A; Lewandowski J
    Pol Tyg Lek; 1981 Jan; 36(3):103-6. PubMed ID: 6113581
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the muscle flow (determinated with 133 xenon) in the lower limbs after intra-arterial injection of acetylcholine in normal subjects and in patients with arterial diseases].
    Nuzzaci G; Fantini F; Viola S; Pesciullesi E; Boccuni M
    Minerva Cardioangiol; 1973; 21(7):503-12. PubMed ID: 4756345
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of delayed-action Tebonin with the study of muscle flow, using xenon 133].
    Matteoni R; Reale R; Lauri D; Sirolli C; Tata MV
    Minerva Cardioangiol; 1973 Apr; 21(4):264-71. PubMed ID: 4710123
    [No Abstract]   [Full Text] [Related]  

  • 14. [Xenon-133 muscle clearance before and after butalamine hydrochloride. Results of a double blind test].
    Zeitler E
    Fortschr Med; 1976 Dec; 94(34):2055-8. PubMed ID: 826469
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of blood supply to muscles during constant load under simplified working conditions using 133-Xe-clearance].
    Hebestreit HP; Wittemann G
    Fortschr Geb Rontgenstr Nuklearmed; 1973; 0(0):suppl:254-5. PubMed ID: 4366647
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adrevil improves the peripheral blood flow. Results of a study using the 133-Xe muscle clearance method on lower limbs].
    Klemm J
    Fortschr Med; 1977 Jul; 95(28):1791-4. PubMed ID: 410717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of venous occlusion on xenon 133 muscle clearance.
    Weber TR; Lindenauer SM; Pozderac RV
    Arch Surg; 1976 Feb; 111(2):178-80. PubMed ID: 1252122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Utiligation of muscular tissue clearance of 133 xenon].
    Mörl H
    Vasa; 1975; 4(2):157-60. PubMed ID: 1136568
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical application of Xe-133 clearance technique in arterial occlusive disease of the leg (author's transl)].
    Hirai M
    Kaku Igaku; 1978 Aug; 15(5):671-8. PubMed ID: 722981
    [No Abstract]   [Full Text] [Related]  

  • 20. Exercise testing using Doppler ultrasound and xenon clearance techniques.
    Yao JS
    Angiology; 1975; 26(7):528-33. PubMed ID: 162567
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.